S&P 500   2,968.34 (-0.06%)
DOW   26,829.06 (+0.05%)
QQQ   191.29 (+0.09%)
AAPL   237.63 (+0.60%)
FB   183.83 (-0.20%)
MSFT   139.93 (+0.18%)
AMZN   1,726.75 (-0.30%)
NVDA   185.67 (-0.17%)
MU   45.04 (-0.16%)
BABA   171.59 (-0.78%)
GE   8.74 (-0.80%)
TSLA   255.45 (+3.05%)
AMD   29.82 (+0.24%)
T   37.43 (-0.43%)
F   8.82 (+0.46%)
ACB   3.49 (-5.43%)
PRI   121.40 (-0.24%)
NFLX   283.10 (+0.06%)
BAC   29.10 (+0.66%)
GILD   64.79 (+1.25%)
DIS   129.87 (-0.12%)
S&P 500   2,968.34 (-0.06%)
DOW   26,829.06 (+0.05%)
QQQ   191.29 (+0.09%)
AAPL   237.63 (+0.60%)
FB   183.83 (-0.20%)
MSFT   139.93 (+0.18%)
AMZN   1,726.75 (-0.30%)
NVDA   185.67 (-0.17%)
MU   45.04 (-0.16%)
BABA   171.59 (-0.78%)
GE   8.74 (-0.80%)
TSLA   255.45 (+3.05%)
AMD   29.82 (+0.24%)
T   37.43 (-0.43%)
F   8.82 (+0.46%)
ACB   3.49 (-5.43%)
PRI   121.40 (-0.24%)
NFLX   283.10 (+0.06%)
BAC   29.10 (+0.66%)
GILD   64.79 (+1.25%)
DIS   129.87 (-0.12%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 Vanda PharmaceuticalsStoke TherapeuticsCapstone TherapeuticsZIOPHARM OncologyKaryopharm Therapeutics
SymbolNASDAQ:VNDANASDAQ:STOKOTCMKTS:CAPSNASDAQ:ZIOPNASDAQ:KPTI
Price Information
Current Price$13.06$21.02$14.10$4.32$10.29
52 Week RangeHoldBuyN/ABuyBuy
Analyst Ratings
Consensus RecommendationHoldBuyN/ABuyBuy
Consensus Price Target$28.67$37.67N/A$6.88$19.33
% Upside from Price Target119.50% upside79.19% upsideN/A59.14% upside87.88% upside
Trade Information
Market Cap$677.59 million$677.27 million$705,000.00$689.21 million$618.59 million
Beta0.32N/A2.472.652.42
Average Volume613,614268,109731,566,7022,015,861
Sales & Book Value
Annual Revenue$193.12 millionN/A$2 million$150,000.00$30.34 million
Price / Sales3.60N/A0.354,681.4421.00
Cashflow$0.56 per shareN/AN/AN/AN/A
Price / Cash23.41N/AN/AN/AN/A
Book Value$5.25 per shareN/A($22.87) per share$0.60 per share$3.02 per share
Price / Book2.49N/A-0.627.203.41
Profitability
Net Income$25.20 millionN/A$-380,000.00$-53,120,000.00$-178,410,000.00
EPS$0.48N/AN/A($0.48)($3.14)
Trailing P/E Ratio26.710.000.00N/AN/A
Forward P/E Ratio15.93N/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins13.61%N/AN/AN/A-2,138.80%
Return on Equity (ROE)10.23%N/AN/A-1,594.01%-154.75%
Return on Assets (ROA)8.32%N/A-193.55%-327.11%-79.47%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/A0.01%1.46%
Current Ratio5.05%50.74%0.86%6.33%6.93%
Quick Ratio5.03%50.74%0.86%6.33%6.93%
Ownership Information
Institutional Ownership PercentageN/A43.43%N/A43.19%82.58%
Insider Ownership Percentage8.20%N/A42.80%2.00%11.63%
Miscellaneous
Employees27044N/A48332
Shares Outstanding53.27 million32.72 million50,000162.55 million61.92 million
Next Earnings Date11/6/2019 (Estimated)11/13/2019 (Estimated)11/12/2019 (Estimated)11/8/2019 (Estimated)11/14/2019 (Estimated)
OptionableOptionableNot OptionableNot OptionableOptionableOptionable
 Vanda PharmaceuticalsStoke TherapeuticsCapstone TherapeuticsZIOPHARM OncologyKaryopharm Therapeutics

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel